CORE LABORATORIES N.V. Accounts Receivable, Allowance for Credit Loss, Current
CORE LABORATORIES N.V. had Accounts Receivable, Allowance for Credit Loss, Current of $2.44 million as of 2023-03-31, per its 10-Q filed 2023-04-27.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2023-04-27
- 2023-03-31: Accounts Receivable, Allowance for Credit Loss, Current $2.44M.
- 2022-12-31: Accounts Receivable, Allowance for Credit Loss, Current $2.21M.
- 2022-09-30: Accounts Receivable, Allowance for Credit Loss, Current $2.36M.
- 2022-06-30: Accounts Receivable, Allowance for Credit Loss, Current $2.31M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current |
|---|---|
| 2023-03-31 | $2.44M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $2.21M 10-Q · filed 2023-04-27 |
| 2022-09-30 | $2.36M 10-Q · filed 2022-10-28 |
| 2022-06-30 | $2.31M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $3.45M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $3.23M 10-K · filed 2023-02-10 |
| 2021-09-30 | $3.64M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $3.81M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $3.92M 10-Q · filed 2021-04-23 |
| 2020-12-31 | $4.07M 10-K · filed 2022-02-10 |
| 2020-09-30 | $3.10M 10-Q · filed 2020-10-22 |
| 2020-06-30 | $3.31M 10-Q · filed 2020-07-24 |
| 2020-03-31 | $2.44M 10-Q · filed 2020-04-24 |
| 2019-12-31 | $2.73M 10-K · filed 2021-02-08 |
| 2019-09-30 | $2.86M 10-Q · filed 2019-10-25 |
| 2019-06-30 | $2.74M 10-Q · filed 2019-07-26 |
| 2019-03-31 | $2.79M 10-Q · filed 2019-04-26 |
| 2018-12-31 | $2.65M 10-K · filed 2020-02-10 |
| 2018-09-30 | $2.84M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $2.47M 10-Q · filed 2018-07-27 |
| 2018-03-31 | $2.64M 10-Q · filed 2018-04-27 |
| 2017-12-31 | $2.59M 10-K · filed 2019-02-11 |
| 2017-09-30 | $3.05M 10-Q · filed 2017-10-25 |
| 2017-06-30 | $2.90M 10-Q · filed 2017-07-26 |
| 2017-03-31 | $3.13M 10-Q · filed 2017-04-21 |
| 2016-12-31 | $3.14M 10-K · filed 2018-02-12 |
| 2016-09-30 | $3.15M 10-Q · filed 2016-10-21 |
| 2016-06-30 | $2.94M 10-Q · filed 2016-07-22 |
| 2016-03-31 | $3.24M 10-Q · filed 2016-04-22 |
| 2015-12-31 | $4.14M 10-K · filed 2017-02-10 |
| 2015-09-30 | $3.75M 10-Q · filed 2015-10-23 |
| 2015-06-30 | $3.73M 10-Q · filed 2015-07-27 |
| 2015-03-31 | $4.23M 10-Q · filed 2015-04-29 |
| 2014-12-31 | $3.40M 10-K · filed 2016-02-12 |
| 2014-09-30 | $3.53M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $3.37M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $2.69M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $2.87M 10-K · filed 2015-02-17 |
| 2013-09-30 | $3.29M 10-Q · filed 2013-10-18 |
| 2013-06-30 | $3.03M 10-Q · filed 2013-07-19 |
| 2013-03-31 | $3.37M 10-Q · filed 2013-04-19 |
| 2012-12-31 | $3.52M 10-K · filed 2014-02-13 |
| 2012-09-30 | $4.04M 10-Q · filed 2012-10-19 |
| 2012-06-30 | $4.12M 10-Q · filed 2012-07-20 |
| 2012-03-31 | $7.07M 10-Q · filed 2012-04-23 |
| 2011-12-31 | $3.76M 10-K · filed 2013-02-19 |
| 2011-09-30 | $3.46M 10-Q · filed 2011-10-25 |
| 2011-06-30 | $3.54M 10-Q · filed 2011-07-29 |
| 2010-12-31 | $3.40M 10-K · filed 2012-02-15 |